Evidence map›Paper›PMID 30620608›Full record

ArticleOrganic letters2019

Meroterpenoids from Neosetophoma sp.: A Dioxa[4.3.3]propellane Ring System, Potent Cytotoxicity, and Prolific Expression.

Tamam El-Elimat, Huzefa A Raja, Sloan Ayers, Steven J Kurina, Joanna E Burdette, Zachary Mattes, Robert Sabatelle, Jeffrey W Bacon, Aaron H Colby, Mark W Grinstaff and 2 more

Abstract read
In one paragraph

Article in Organic letters, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Understanding and Engineering the Stereoselectivity of Humulene Synthase.Angewandte Chemie (International ed. in English) · 2021
    Article
  16. Review
  17. Article
  18. Peculiarities of meroterpenoids and their bioproduction.Applied microbiology and biotechnology · 2021
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Tamam El-ElimatDepartment of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy , Jordan University of Science and Technology , Irbid 22110 , Jordan.
Huzefa A RajaDepartment of Chemistry and Biochemistry , University of North Carolina at Greensboro , Greensboro , North Carolina 27402 , United States.ORCID 0000-0002-0824-9463
Sloan AyersDepartment of Chemistry and Biochemistry , University of North Carolina at Greensboro , Greensboro , North Carolina 27402 , United States.
Steven J KurinaDepartment of Medicinal Chemistry and Pharmacognosy , University of Illinois at Chicago , Chicago , Illinois 60612 , United States.
Joanna E BurdetteDepartment of Medicinal Chemistry and Pharmacognosy , University of Illinois at Chicago , Chicago , Illinois 60612 , United States.
Zachary MattesDepartment of Chemistry , Boston University , Boston , Massachusetts 02215 , United States.
Robert SabatelleDepartment of Biomedical Engineering , Boston University , Boston , Massachusetts 02215 , United States.
Jeffrey W BaconDepartment of Chemistry , Boston University , Boston , Massachusetts 02215 , United States.
Aaron H ColbyDepartment of Biomedical Engineering , Boston University , Boston , Massachusetts 02215 , United States.
Mark W GrinstaffDepartment of Chemistry , Boston University , Boston , Massachusetts 02215 , United States.ORCID 0000-0002-5453-3668
Cedric J PearceMycosynthetix, Inc. , Hillsborough , North Carolina 27278 , United States.
Nicholas H OberliesDepartment of Chemistry and Biochemistry , University of North Carolina at Greensboro , Greensboro , North Carolina 27402 , United States.ORCID 0000-0002-0354-8464
Boston University · USUniversity of North Carolina at Greensboro · USUniversity of Illinois Chicago · USJordan University of Science and Technology · JOMycosynthetix (United States) · US

Funding

Project 3:Isolation Chemistry of Filamentous Fungi and Biological EvaluationP01CA125066 · NCI · OHIO STATE UNIVERSITY · PI Joanna E Burdette · 2007 to 2026
$27.2M
Translational Research in BiomaterialsT32EB006359 · NIBIB · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI MARK W. GRINSTAFF, Michelle H Teplensky · 2009 to 2026
$4.2M
TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCER01CA227433 · NCI · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI COLSON, YOLONDA L, GRINSTAFF, MARK W. · 2018 to 2022
$2.7M
NCI NIH HHS P01 CA125066NCI NIH HHS R01 CA227433NIBIB NIH HHS T32 EB006359
6 · The paper itself

Abstract

Six fungal metabolites, of which five were new, including one (1) with a dioxa[4.3.3]propellane ring system, were discovered, identified, and structurally elucidated from Neosetophoma sp. (strain MSX50044); these compounds are similar to the bis-tropolone, eupenifeldin. Three of the meroterpenoids are potent cytotoxic agents against breast, ovarian, mesothelioma, and lung cancer cells with nanomolar IC

Indexed as

Antineoplastic AgentsAscomycotaHumansMolecular StructureTerpenesAntineoplastic AgentsTerpenes

Identifiers

PMID30620608
PMCPMC6343109
OpenAlexW2909327207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.